Thursday, December 29, 2022

Clinical experience with the α2A-adrenoceptor agonist, guanfacine, and N-acetylcysteine for the treatment of cognitive deficits in “Long-COVID19”

 https://www.sciencedirect.com/science/article/pii/S2667257X22001000

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)